Heat Shock Protein 105 as an Immunotherapeutic Target for Patients With Cervical Cancer. Nosaka K, Suzuki S, Yoshikawa T, Shimomura M, et al. Anticancer Res 2021;41:4741-4751.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nosaka K, Suzuki S, Yoshikawa T, Shimomura M, et al. Heat Shock Protein 105 as an Immunotherapeutic Target for Patients With Cervical Cancer. Anticancer Res 2021;41:4741-4751.
PMID: 34593423